Oxbow Advisors LLC boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 20.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 28,021 shares of the healthcare conglomerate’s stock after acquiring an additional 4,850 shares during the period. UnitedHealth Group accounts for about 1.0% of Oxbow Advisors LLC’s holdings, making the stock its 24th biggest position. Oxbow Advisors LLC’s holdings in UnitedHealth Group were worth $8,238,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in UNH. Cerebellum GP LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at approximately $80,000. SeaCrest Wealth Management LLC lifted its position in UnitedHealth Group by 3.4% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 2,981 shares of the healthcare conglomerate’s stock valued at $648,000 after acquiring an additional 97 shares in the last quarter. Massey Quick Simon & CO. LLC lifted its position in UnitedHealth Group by 212.5% in the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after acquiring an additional 119 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at approximately $345,000. Finally, Ingalls & Snyder LLC raised its stake in UnitedHealth Group by 4.3% during the 3rd quarter. Ingalls & Snyder LLC now owns 3,622 shares of the healthcare conglomerate’s stock valued at $787,000 after buying an additional 148 shares during the last quarter. Institutional investors and hedge funds own 85.81% of the company’s stock.
Shares of UNH traded down $3.42 during midday trading on Friday, hitting $298.78. 2,485,482 shares of the company traded hands, compared to its average volume of 4,046,964. The firm has a 50 day moving average of $291.30 and a 200-day moving average of $260.18. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $305.90. The stock has a market cap of $271.94 billion, a price-to-earnings ratio of 20.85, a PEG ratio of 1.41 and a beta of 0.69. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.70 and a current ratio of 0.69.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $299.45, for a total transaction of $4,491,750.00. Following the completion of the transaction, the director now owns 158,598 shares of the company’s stock, valued at approximately $47,492,171.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP D Ellen Wilson sold 7,400 shares of the stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. 0.82% of the stock is owned by corporate insiders.
A number of brokerages have weighed in on UNH. Barclays reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Sunday, January 19th. Wells Fargo & Co reiterated an “overweight” rating and set a $335.00 target price (up from $318.00) on shares of UnitedHealth Group in a research note on Wednesday, December 11th. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $276.00 to $361.00 and gave the company an “overweight” rating in a research note on Friday, December 20th. Piper Jaffray Companies boosted their target price on shares of UnitedHealth Group from $312.00 to $325.00 and gave the company an “overweight” rating in a research note on Wednesday, December 4th. Finally, Morgan Stanley reiterated a “buy” rating and set a $312.00 target price (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Five analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $313.50.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Differences Between Momentum Investing and Long Term Investing
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.